SCHEMBL13571237

SCHEMBL13571237

CCc1cc(C=O)ccc1C#N

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.39
ALDH1A3 P47895 4/20 0.38
ALDH3A1 P30838 3/20 0.37
TSHR P16473 1/20 0.36
EGFR P00533 1/20 0.36
KDM4E B2RXH2 1/20 0.35
PTGS2 P35354 1/20 0.35
RAB9A P51151 1/20 0.35
HSD17B10 Q99714 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
FDPS P14324 1/20 0.35
AR P10275 1/20 0.35
CYP2A6 P11509 2/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13571069 0.88 ALDH1A1 (0.37) ALDH1A1ALDH1A3ALDH3A1TSHREGFR
SCHEMBL13630983 0.85 ALDH1A1 (0.40) ALDH1A1ALDH1A3ALDH3A1TSHREGFR
SCHEMBL7896888 0.80 ALDH1A1 (0.40) ALDH1A1KDM4ERAB9ALMNAMAPT
SCHEMBL7896891 0.80 ALDH1A1 (0.40) ALDH1A1KDM4ERAB9ALMNAMAPT
SCHEMBL24025599 0.79 ALDH1A1 (0.37) ALDH1A1TSHREGFRKDM4EPTGS2
SCHEMBL7575302 0.79 AR (0.38) ALDH1A1KDM4ERAB9AARMAPT
SCHEMBL6899726 0.78 ALDH1A1 (0.47) ALDH1A1TSHREGFRKDM4EPTGS2
SCHEMBL1795902 0.77 TSHR (0.43) ALDH1A1ALDH1A3TSHREGFRKDM4E
SCHEMBL1982932 0.77 KDM4E (0.52) ALDH1A1TSHRKDM4EHSD17B10AR
SCHEMBL30902412 0.76 ALDH1A1 (0.55) ALDH1A1TSHRKDM4ETDP1FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012152983-A1 PHENYL- SULFONYL DERIVATIVES AS MEDIATORS OF TRPA1 RECEPTOR ACTIVITY FOR THE TREATMENT OF PAIN ORION CORPORATION (FI) 2012-11-15 WO disclosed
EP-2520566-A1 New Pharmaceutical Compounds Orion Corporation (FI) 2012-11-07 EP disclosed